NUTLEY, N.J.--(BUSINESS WIRE)--July 17, 2006--Roche today released a comprehensive guide to help facilitate pandemic influenza planning among U.S.-based businesses, many of which are not yet fully prepared for the potential public health crisis and its impact on their organizations, according to several recent surveys. The new, 70-page on-line Toolkit (www.PandemicToolkit.com) provides information and practical advice in response to questions posed by business managers about the avian flu threat in general, and the role of antivirals, in particular. Roche manufactures Tamiflu® (oseltamivir phosphate), the only oral antiviral medication that has shown activity in vitro and in animal studies against the H5N1 strain of bird flu, which experts fear could cause a global influenza pandemic.
